Novo Nordisk is facing serious pressure from a powerful adversary. It still has plenty of leeway to penetrate its target market, for now. Investors should keep a close eye on this company. But it ...
Novo stock prices fell by more than 3% when the U.S. market opened approximately two hours after the announcement came from the Centers for Medicare and Medicaid Services. Three of Novo’s ...